23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › PACIRA BIOSCIENCES INC. › 2023-2024

PACIRA BIOSCIENCES INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and PACIRA BIOSCIENCES INC.’s Form 8-K, filed June 13, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 6Ballot items
  • 314Asset managers, any item
  • 2,073Fund votes
  • June 11, 2024Meeting date

Results at a glance

Meeting of June 11, 2024: 6 items on PACIRA BIOSCIENCES INC.’s Form 8-K, filed June 13, 2024: 5 passed (calculated) · 1 plurality election.

Dissent

Significant dissent: 2 directors (50.1%, 24.6% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Doma Perpetual Capital Management LLC (as of June 9, 2026)

Explore PACIRA BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by PACIRA BIOSCIENCES INC.

These tallies are PACIRA BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PACIRA BIOSCIENCES INC. — official shareholder meeting results, meeting held June 11, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Laura Brege 20,659,043---- 20,779,8992,676,760 49.9%Plurality election—
Elect Director: Mark Froimson 40,275,000---- 1,163,9422,676,760 97%Passed (calculated)—
Elect Director: Mark Kronenfeld 31,252,640---- 10,186,3022,676,760 75%Passed (calculated)—
Elect Director: Michael Yang 40,666,349---- 772,5932,676,760 98%Passed (calculated)—
2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 43,901,001204,07410,627 ---- 99.5%Passed (calculated)—
3. Advisory vote to approve the compensation of the Company's named executive officers 37,228,9834,087,635122,324 --2,676,760 90%Passed (calculated)—

Source: PACIRA BIOSCIENCES INC., Form 8-K, filed with the SEC on June 13, 2024 — read the filing on EDGAR.

How asset managers voted at the PACIRA BIOSCIENCES INC. 2023-2024 meeting

314 asset managers disclosed a vote on at least one PACIRA BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Laura Brege

Calculated outcomeDIRECTOR ELECTIONSPlurality election

Combines 4 wordings of this item as funds reported it.

49.9% Plurality election · of votes cast

FOR 49.9%WITHHELD
FOR: 20,659,043WITHHELD: 20,779,899
Details: description as filed, official tally, votes by 95 asset managers

Description as filed by funds: Election of Directors: Laura Brege

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Laura Brege”): 20,659,043 for, 20,779,899 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.

Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 49.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 95 asset managers below reported 10,346,987 for, 14,332,622 withheld, 161,569 abstained, 1,701 unknown.

FORWITHHOLD
FOR: 10,346,987ABSTAIN: 161,569WITHHOLD: 14,332,622UNKNOWN: 1,701
Largest asset managers voting on “Election of Directors: Laura Brege” at PACIRA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard857,5680 04,977,372Mixed
BlackRock00 05,376,254Withhold
Pacer Funds Trust1,620,0240 00For
Dimensional1,405,7690 00For
Delaware/Macquarie00 01,296,449Withhold
Fidelity963,7590 034,110For
Legg Mason997,4400 00For
State Street14,2080 0838,646Withhold
JANUS INVESTMENT FUND556,8790 00For
TIAA406,0000 00For
Charles Schwab396,0130 00For
Invesco00 0362,028Withhold
DWS00 0344,696Withhold
GLENMEDE FUND INC330,2140 00For
IMPAX FUNDS SERIES TRUST I260,0270 00For
Columbia Threadneedle196,9610 00For
T. Rowe Price00 0194,586Withhold
Aberdeen192,1890 00For
Bridge Builder Trust181,3380 8,5290For
Jackson National178,8000 00For
OLD WESTBURY FUNDS INC174,8210 00For
Empower35,0570 0119,034Mixed
NICHOLAS Ltd EDITION, INC.152,3500 00For
AMERICAN BEACON FUNDS135,7200 00For
Nuveen134,8890 00For

Showing the 25 largest of 95 asset managers. All 95 are in the interactive database (link above).

Elect Director: Mark Froimson

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 40,275,000WITHHELD: 1,163,942
Details: description as filed, official tally, votes by 95 asset managers

Description as filed by funds: Election of Directors: Mark Froimson

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Mark Froimson”): 40,275,000 for, 1,163,942 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 95 asset managers below reported 24,511,662 for, 318,496 withheld, 11,020 abstained, 1,701 unknown.

FOR
FOR: 24,511,662ABSTAIN: 11,020WITHHOLD: 318,496UNKNOWN: 1,701
Largest asset managers voting on “Election of Directors: Mark Froimson” at PACIRA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard5,834,9400 00For
BlackRock5,376,2540 00For
Pacer Funds Trust1,620,0240 00For
Dimensional1,405,7690 00For
Delaware/Macquarie1,296,4490 00For
Fidelity997,8690 00For
Legg Mason997,4400 00For
State Street851,5150 01,339For
JANUS INVESTMENT FUND556,8790 00For
TIAA406,0000 00For
Charles Schwab396,0130 00For
Invesco362,0280 00For
DWS344,6960 00For
GLENMEDE FUND INC330,2140 00For
IMPAX FUNDS SERIES TRUST I260,0270 00For
Columbia Threadneedle196,9610 00For
T. Rowe Price00 0194,586Withhold
Aberdeen192,1890 00For
Bridge Builder Trust189,8670 00For
Jackson National178,8000 00For
OLD WESTBURY FUNDS INC174,8210 00For
Empower154,0910 00For
NICHOLAS Ltd EDITION, INC.152,3500 00For
AMERICAN BEACON FUNDS135,7200 00For
Nuveen134,8890 00For

Showing the 25 largest of 95 asset managers. All 95 are in the interactive database (link above).

Elect Director: Mark Kronenfeld

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 5 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD
FOR: 31,252,640WITHHELD: 10,186,302
Details: description as filed, official tally, votes by 95 asset managers

Description as filed by funds: Election of Directors: Mark Kronenfeld

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Mark Kronenfeld”): 31,252,640 for, 10,186,302 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 95 asset managers below reported 20,416,582 for, 4,251,856 withheld, 172,740 abstained, 1,701 unknown.

FORWITHHOLD
FOR: 20,416,582ABSTAIN: 172,740WITHHOLD: 4,251,856UNKNOWN: 1,701
Largest asset managers voting on “Election of Directors: Mark Kronenfeld” at PACIRA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard5,655,6610 0179,279For
BlackRock5,376,2540 00For
Pacer Funds Trust1,620,0240 00For
Dimensional1,405,7690 00For
Delaware/Macquarie00 01,296,449Withhold
Fidelity997,8690 00For
Legg Mason997,4400 00For
State Street14,2080 0838,646Withhold
JANUS INVESTMENT FUND556,8790 00For
TIAA406,0000 00For
Charles Schwab00 0396,013Withhold
Invesco00 0362,028Withhold
DWS344,6960 00For
GLENMEDE FUND INC330,2140 00For
IMPAX FUNDS SERIES TRUST I00 0260,027Withhold
Columbia Threadneedle196,9610 00For
T. Rowe Price00 0194,586Withhold
Aberdeen192,1890 00For
Bridge Builder Trust189,8670 00For
Jackson National178,8000 00For
OLD WESTBURY FUNDS INC174,8210 00For
Empower00 0154,091Withhold
NICHOLAS Ltd EDITION, INC.152,3500 00For
AMERICAN BEACON FUNDS135,7200 00For
Nuveen134,8890 00For

Showing the 25 largest of 95 asset managers. All 95 are in the interactive database (link above).

Elect Director: Michael Yang

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 40,666,349WITHHELD: 772,593
Details: description as filed, official tally, votes by 95 asset managers

Description as filed by funds: Election of Directors: Michael Yang

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Michael Yang”): 40,666,349 for, 772,593 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 95 asset managers below reported 24,820,067 for, 10,091 withheld, 11,020 abstained, 1,701 unknown.

FOR
FOR: 24,820,067ABSTAIN: 11,020WITHHOLD: 10,091UNKNOWN: 1,701
Largest asset managers voting on “Election of Directors: Michael Yang” at PACIRA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard5,834,9400 00For
BlackRock5,376,2540 00For
Pacer Funds Trust1,620,0240 00For
Dimensional1,405,7690 00For
Delaware/Macquarie1,296,4490 00For
Fidelity997,8690 00For
Legg Mason997,4400 00For
State Street852,8540 00For
JANUS INVESTMENT FUND556,8790 00For
TIAA406,0000 00For
Charles Schwab396,0130 00For
Invesco362,0280 00For
DWS344,6960 00For
GLENMEDE FUND INC330,2140 00For
IMPAX FUNDS SERIES TRUST I260,0270 00For
Columbia Threadneedle196,9610 00For
T. Rowe Price194,5860 00For
Aberdeen192,1890 00For
Bridge Builder Trust189,8670 00For
Jackson National178,8000 00For
OLD WESTBURY FUNDS INC174,8210 00For
Empower154,0910 00For
NICHOLAS Ltd EDITION, INC.152,3500 00For
AMERICAN BEACON FUNDS135,7200 00For
Nuveen134,8890 00For

Showing the 25 largest of 95 asset managers. All 95 are in the interactive database (link above).

Advisory vote to approve the compensation of the Company's named executive officers

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 10 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%
FOR: 37,228,983AGAINST: 4,087,635

Prior year: 86.7% for (June 13, 2023 meeting) ▲ 3.4 pts

Details: description as filed, official tally, votes by 313 asset managers

Description as filed by funds: Approval, on an advisory basis, of the compensation of our named executive officers.

PACIRA BIOSCIENCES INC.’s own tally for this item (“3. Advisory vote to approve the compensation of the Company's named executive officers”): 37,228,983 for, 4,087,635 against, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 100 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at PACIRA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard5,834,9400 00For
BlackRock5,376,2540 00For
Pacer Funds Trust1,620,0240 00For
Dimensional1,405,7690 00For
Delaware/Macquarie1,296,4490 00For
Fidelity997,8690 00For
Legg Mason997,4400 00For
State Street852,8540 00For
JANUS INVESTMENT FUND556,8790 00For
TIAA406,0000 00For
Charles Schwab396,0130 00For
Invesco362,0280 00For
DWS344,6960 00For
GLENMEDE FUND INC330,2140 00For
IMPAX FUNDS SERIES TRUST I260,0270 00For
Columbia Threadneedle196,9610 00For
T. Rowe Price194,5860 00For
Aberdeen0192,189 00Against
Bridge Builder Trust189,8670 00For
Jackson National178,8000 00For
OLD WESTBURY FUNDS INC174,8210 00For
Tributary Funds, Inc.163,5350 00For
Empower154,0910 00For
NICHOLAS Ltd EDITION, INC.152,3500 00For
AMERICAN BEACON FUNDS135,7200 00For

Fund voting reports, all 100 managers: 24,811,636 for, 319,894 against, 4,474 abstained, 1,701 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 236 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at PACIRA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,741,4410 00For
BlackRock1,728,777416 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST1,418,3910 00For
Clearbridge Investments, LLC1,171,9770 00For
Stephens Investment Management Group LLC1,090,8380 00For
GEODE CAPITAL MANAGEMENT, LLC1,023,6000 00For
Rock Springs Capital Management LP976,2760 00For
FRONTIER CAPITAL MANAGEMENT CO LLC933,07030,037 00For
RICE HALL JAMES & ASSOCIATES, LLC14,415724,563 00Against
Janus Henderson578,7410 00For
BAILLIE GIFFORD & CO LTD0576,803 00Against
SCHRODER INVESTMENT MANAGEMENT GROUP0576,121 00Against
Nuveen566,6150 00For
Aberdeen0523,545 00Against
Northern Trust469,28230 00For
Charles Schwab416,9320 00For
Archon Capital Management LLC00 00--
Invesco380,9900 00For
MELLON INVESTMENTS Corp373,2610 00For
Loomis Sayles348,8060 00For
ARDSLEY ADVISORY PARTNERS LP331,7120 00For
T. Rowe Price310,2710 00For
PRINCIPAL GLOBAL INVESTORS264,1930 00For
Tributary Capital Management, LLC233,7550 00For
Wellington229,7030 00For

Institutional-manager reports, all 236 managers: 18,106,900 for, 3,067,527 against, 2,114 abstained, 7,558 not voted, 395,035 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 7 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 43,901,001AGAINST: 204,074

Prior year: 99.3% for (June 13, 2023 meeting) ▲ 0.2 pts

Details: description as filed, official tally, votes by 103 asset managers

Description as filed by funds: Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.

PACIRA BIOSCIENCES INC.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 43,901,001 for, 204,074 against, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 103 asset managers below reported 25,173,323 for, 652 against, 4,474 abstained, 1,701 unknown.

FOR
FOR: 25,173,323AGAINST: 652ABSTAIN: 4,474UNKNOWN: 1,701
Largest asset managers voting on “Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fisca” at PACIRA BIOSCIENCES INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard5,834,9400 00For
BlackRock5,376,2540 00For
Pacer Funds Trust1,620,0240 00For
Dimensional1,405,7690 00For
Delaware/Macquarie1,296,4490 00For
Fidelity997,8690 00For
Legg Mason997,4400 00For
State Street852,202652 00For
JANUS INVESTMENT FUND556,8790 00For
TIAA406,0000 00For
Charles Schwab396,0130 00For
Invesco362,0280 00For
DWS344,6960 00For
GLENMEDE FUND INC330,2140 00For
IMPAX FUNDS SERIES TRUST I260,0270 00For
Columbia Threadneedle196,9610 00For
T. Rowe Price194,5860 00For
Aberdeen192,1890 00For
Bridge Builder Trust189,8670 00For
Jackson National178,8000 00For
OLD WESTBURY FUNDS INC174,8210 00For
Tributary Funds, Inc.163,5350 00For
Empower154,0910 00For
NICHOLAS Ltd EDITION, INC.152,3500 00For
AMERICAN BEACON FUNDS135,7200 00For

Showing the 25 largest of 103 asset managers. All 103 are in the interactive database (link above).

Largest PACIRA BIOSCIENCES INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 46,517,410 shares outstanding at the time of that meeting.

Fund voting reports: top PACIRA BIOSCIENCES INC. shareholders by shares voted on “Ratification of the appointment of KPMG LLP as our independent registered public accounting…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 12.54%
2BlackRock 11.56%
3Pacer Funds Trust 3.48%
4Dimensional 3.02%
5Delaware/Macquarie 2.79%
6Fidelity 2.15%
7Legg Mason 2.14%
8State Street 1.83%
9JANUS INVESTMENT FUND 1.20%
10TIAA 0.87%
Institutional-manager reports: top PACIRA BIOSCIENCES INC. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of our named executive officers.”, 2023-2024
#Asset manager % of shares outstanding
1State Street 3.74%
2BlackRock 3.72%
3MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST 3.05%
4Clearbridge Investments, LLC 2.52%
5Stephens Investment Management Group LLC 2.35%
6GEODE CAPITAL MANAGEMENT, LLC 2.20%
7Rock Springs Capital Management LP 2.10%
8FRONTIER CAPITAL MANAGEMENT CO LLC 2.07%
9RICE HALL JAMES & ASSOCIATES, LLC 1.59%
10Janus Henderson 1.24%

Reported PACIRA BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

PACIRA BIOSCIENCES INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock7,336,198 15.77%Form 13F, quarter ended March 31, 2024
Vanguard Group5,197,567 11.17%Form 13F, quarter ended March 31, 2024
State Street1,903,612 4.09%Form 13F, quarter ended March 31, 2024
Renaissance Technologies1,882,197 4.05%Form 13F, quarter ended March 31, 2024
Dimensional Fund Advisors1,629,129 3.50%Form 13F, quarter ended March 31, 2024
Goldman Sachs1,309,988 2.82%Form 13F, quarter ended March 31, 2024
Morgan Stanley1,142,762 2.46%Form 13F, quarter ended March 31, 2024
Geode Capital1,036,681 2.23%Form 13F, quarter ended March 31, 2024
Nuveen566,713 1.22%Form 13F, quarter ended March 31, 2024
Invesco550,659 1.18%Form 13F, quarter ended March 31, 2024

Percentages above are of 46,517,410 shares outstanding, as reported by PACIRA BIOSCIENCES INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At PACIRA BIOSCIENCES INC.'s shareholder meeting held June 11, 2024, in the 2023-2024 proxy season, 314 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 2,073 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of our named executive officers. — FOR was 90% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PACIRA BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PACIRA BIOSCIENCES INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

PACIRA BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “PACIRA BIOSCIENCES (PCRX) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/pacira-biosciences-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.